Lawrence J. Ellison Ambulatory Care Center
4860 Y St., Suite 2820
Sacramento, CA 95817
4860 Y St., Suite 2100
Sacramento, CA 95817
Additional Phone Numbers
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Dr. Laird is an internationally renowned interventional cardiologist who has lectured and performed endovascular procedures around the world. His practice focuses on interventions for carotid artery disease, abdominal and thoracic aortic aneurysmal disease, renal artery disease and peripheral artery disease. Among his many areas of leadership and innovation are the investigation of new stents for carotid and peripheral vascular applications and the development of laser angioplasty. He uses the Excimer laser as a tool for complex peripheral interventions and in limb salvage situations. UC Davis Health System's acquisition of a laser in the summer of 2006 will allow the Vascular Center to add laser atherectomy to its clinical services. Dr. Laird is known for innovation, teaching vascular interventions to other physicians, and his role in organizing and conducting clinical trials of new therapies for vascular disease.
M.D., Albany Medical College, Albany, New York, 1984
Madigan Army Medical Center, Tacoma, Washington, 1987
Walter Reed Army Medical Center, Washington, District of Columbia, 1990
American Board of Internal Medicine, 1987
American Board of Internal Medicine, Cardiovascular Disease, 1989
American Board of Internal Medicine, Interventional Cardiology, 1999
Select Recent Publications
Laird JR, Rundback J, Zierler E, Becker GJ, S'Shaughnessy CO, Shuck J, Allie D, Olin JW, Cantwell-Gabb K, Thomas J. Safety and efficacy of the Bridge Extra Support over-the-wire renal stent system following suboptimal renal angioplasty for de novo and restenotic ostial lesions. J Am Interv Radiol. 2010 May;21(5):627-37.
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc interven. 2010 Jun 1;3(3):267-76. Epub 2010 may 18.
Laird JR, Dawson DL. The role for Cryoplasty in the treatment of infrainguinal artery disease: case studies. J Endovasc Ther 2009;16(Suppl 2):116-28.
Tan WC, Yeo KK, Laird JR. Excimer laser assisted angioplasty for complex infrainguinal peripheral artery disease: a 2008 update. J Cardiovasc Surg 2008; 49:329-40.
Yeo KK, Dawson D, Brooks JL, Laird JR. Percutaneous treatment of a large superior mesenteric artery pseudoaneurysm and arterio-venous fistula: a case report. J Vasc Surgery 2008;48:730-2.
Yeo KK, Rogers JH, Laird JR. Use of stent grafts and coils in vessel perforation and rupture. J Interven Cardiol 2008;21:86-99.
Laird JR, Pevec WC. Carotid stenting for total occlucion of the internal carotid artery: Dogma debunked? Circ Cardiovasc Interven. 2008 Oct;1(2):93-4.
Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman P, Goldman C, McEllin K, Kelly R, Chronos N. Constitutively active HIF1- a transgene as a therapeutic strategy in no-option critical limb ischemia patients: results from a double-blinded, randomized, controlled clinical trial. Circulation 2007;115:1234-1243.
Rogers JH, Laird JR. Overview of New Technologies for Lower Extremity Revascularization. Circulation 2007;116:2072-2085.
Laird JR, Zeller T, Gray BH, Scheinert D, Vranic M, Reiser C, Biamino G. Limb salvage following laser assisted angioplasty for critical limb ischemia: Results of the LACI multicenter trial. J Endovasc Ther 2006;13:1-11.
Laird JR. Contrast delivery and patient safety during peripheral interventions. J Invasive Cardiol 2006;(suppl A):21-25.
Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006;13(Suppl II):II-30-II-40.
Laird JR, Biamino G, McNamara T, Scheinert D, Zetterlund P, Moen E, Joye JD. Cryoplasty for the treatment of femoropopliteal arerial disease: Extended follow-up results. J Endovasc Ther 2006;13(Suppl II):II-52-II-59.